Virtual screening and molecular docking of Indonesian phytoconstituents as potential inhibitors of peroxisome proliferator-activated receptor gamma in polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) is the most common endocrinology disorder affecting women of reproductive age, characterized by irregular menstruation, androgen overproduction and insulin resistance. Peroxisome proliferator-activated receptor-gamma (PPARG) is one of the essential modulators of ovar...

Full description

Saved in:
Bibliographic Details
Main Authors: Tunjungseto Arif, Iffatunnisa Fakhriyah, Pratiwi Intan Winta, Alif Azzam Muhyiddin Afrizal, Ahsan Fadhil, Santoso Budi
Format: Article
Language:English
Published: EDP Sciences 2025-01-01
Series:BIO Web of Conferences
Online Access:https://www.bio-conferences.org/articles/bioconf/pdf/2025/05/bioconf_icgrc2025_02003.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832098673407819776
author Tunjungseto Arif
Iffatunnisa Fakhriyah
Pratiwi Intan Winta
Alif Azzam Muhyiddin Afrizal
Ahsan Fadhil
Santoso Budi
author_facet Tunjungseto Arif
Iffatunnisa Fakhriyah
Pratiwi Intan Winta
Alif Azzam Muhyiddin Afrizal
Ahsan Fadhil
Santoso Budi
author_sort Tunjungseto Arif
collection DOAJ
description Polycystic ovary syndrome (PCOS) is the most common endocrinology disorder affecting women of reproductive age, characterized by irregular menstruation, androgen overproduction and insulin resistance. Peroxisome proliferator-activated receptor-gamma (PPARG) is one of the essential modulators of ovarian steroid hormone synthesis and lipid metabolism. Precision medicine and targeted therapy have emerged as practical therapeutic approaches, focusing on specific molecules/pathways to minimize side effects and improve outcomes. This study aimed to identify potential Indonesian phytoconstituents that inhibit PPARG both from a pharmacokinetic and pharmacodynamic perspective based on the in silico approach. Data of 6776 phytoconstituents from the Indonesian Medicinal Plant Database were screened for compounds with Pa>0.3 as “Insulin Sensitivity”, “Lipid metabolism”, and “Anti-inflammation” using PASSOnline. We performed pharmacokinetic profile prediction using SwissADME based on Lipinski criteria. Molecular docking was carried out with PPARG as the target proteins, utilizing PyMol, Pyrx, and Discovery Studio to evaluate top-hit compounds with the highest binding affinity. Through in silico screening and molecular docking, Quercitol exhibited superior binding with the protein target compared to the control ligands and metformin. Quercitol also met the Lipinski criteria, showing favourable bioavailability as a drug candidate. Hence, these findings will provide a theoretical basis for further studies as regards drugs targeting PPARG in PCOS.
format Article
id doaj-art-12182091c2c74d52a92e93980ec23bed
institution Kabale University
issn 2117-4458
language English
publishDate 2025-01-01
publisher EDP Sciences
record_format Article
series BIO Web of Conferences
spelling doaj-art-12182091c2c74d52a92e93980ec23bed2025-02-05T10:43:07ZengEDP SciencesBIO Web of Conferences2117-44582025-01-011540200310.1051/bioconf/202515402003bioconf_icgrc2025_02003Virtual screening and molecular docking of Indonesian phytoconstituents as potential inhibitors of peroxisome proliferator-activated receptor gamma in polycystic ovary syndromeTunjungseto Arif0Iffatunnisa Fakhriyah1Pratiwi Intan Winta2Alif Azzam Muhyiddin Afrizal3Ahsan Fadhil4Santoso Budi5Department of Obstetrics and Gynecology, Faculty of Medicine, Airlangga UniversityDepartment of Obstetrics and Gynecology, Faculty of Medicine, Airlangga UniversityDepartment of Obstetrics and Gynecology, Faculty of Medicine, Airlangga UniversityDepartment of Pediatrics, Faculty of Medicine, Airlangga UniversityDepartment of Obstetrics and Gynecology, Faculty of Medicine, Airlangga UniversityDepartment of Obstetrics and Gynecology, Faculty of Medicine, Airlangga UniversityPolycystic ovary syndrome (PCOS) is the most common endocrinology disorder affecting women of reproductive age, characterized by irregular menstruation, androgen overproduction and insulin resistance. Peroxisome proliferator-activated receptor-gamma (PPARG) is one of the essential modulators of ovarian steroid hormone synthesis and lipid metabolism. Precision medicine and targeted therapy have emerged as practical therapeutic approaches, focusing on specific molecules/pathways to minimize side effects and improve outcomes. This study aimed to identify potential Indonesian phytoconstituents that inhibit PPARG both from a pharmacokinetic and pharmacodynamic perspective based on the in silico approach. Data of 6776 phytoconstituents from the Indonesian Medicinal Plant Database were screened for compounds with Pa>0.3 as “Insulin Sensitivity”, “Lipid metabolism”, and “Anti-inflammation” using PASSOnline. We performed pharmacokinetic profile prediction using SwissADME based on Lipinski criteria. Molecular docking was carried out with PPARG as the target proteins, utilizing PyMol, Pyrx, and Discovery Studio to evaluate top-hit compounds with the highest binding affinity. Through in silico screening and molecular docking, Quercitol exhibited superior binding with the protein target compared to the control ligands and metformin. Quercitol also met the Lipinski criteria, showing favourable bioavailability as a drug candidate. Hence, these findings will provide a theoretical basis for further studies as regards drugs targeting PPARG in PCOS.https://www.bio-conferences.org/articles/bioconf/pdf/2025/05/bioconf_icgrc2025_02003.pdf
spellingShingle Tunjungseto Arif
Iffatunnisa Fakhriyah
Pratiwi Intan Winta
Alif Azzam Muhyiddin Afrizal
Ahsan Fadhil
Santoso Budi
Virtual screening and molecular docking of Indonesian phytoconstituents as potential inhibitors of peroxisome proliferator-activated receptor gamma in polycystic ovary syndrome
BIO Web of Conferences
title Virtual screening and molecular docking of Indonesian phytoconstituents as potential inhibitors of peroxisome proliferator-activated receptor gamma in polycystic ovary syndrome
title_full Virtual screening and molecular docking of Indonesian phytoconstituents as potential inhibitors of peroxisome proliferator-activated receptor gamma in polycystic ovary syndrome
title_fullStr Virtual screening and molecular docking of Indonesian phytoconstituents as potential inhibitors of peroxisome proliferator-activated receptor gamma in polycystic ovary syndrome
title_full_unstemmed Virtual screening and molecular docking of Indonesian phytoconstituents as potential inhibitors of peroxisome proliferator-activated receptor gamma in polycystic ovary syndrome
title_short Virtual screening and molecular docking of Indonesian phytoconstituents as potential inhibitors of peroxisome proliferator-activated receptor gamma in polycystic ovary syndrome
title_sort virtual screening and molecular docking of indonesian phytoconstituents as potential inhibitors of peroxisome proliferator activated receptor gamma in polycystic ovary syndrome
url https://www.bio-conferences.org/articles/bioconf/pdf/2025/05/bioconf_icgrc2025_02003.pdf
work_keys_str_mv AT tunjungsetoarif virtualscreeningandmoleculardockingofindonesianphytoconstituentsaspotentialinhibitorsofperoxisomeproliferatoractivatedreceptorgammainpolycysticovarysyndrome
AT iffatunnisafakhriyah virtualscreeningandmoleculardockingofindonesianphytoconstituentsaspotentialinhibitorsofperoxisomeproliferatoractivatedreceptorgammainpolycysticovarysyndrome
AT pratiwiintanwinta virtualscreeningandmoleculardockingofindonesianphytoconstituentsaspotentialinhibitorsofperoxisomeproliferatoractivatedreceptorgammainpolycysticovarysyndrome
AT alifazzammuhyiddinafrizal virtualscreeningandmoleculardockingofindonesianphytoconstituentsaspotentialinhibitorsofperoxisomeproliferatoractivatedreceptorgammainpolycysticovarysyndrome
AT ahsanfadhil virtualscreeningandmoleculardockingofindonesianphytoconstituentsaspotentialinhibitorsofperoxisomeproliferatoractivatedreceptorgammainpolycysticovarysyndrome
AT santosobudi virtualscreeningandmoleculardockingofindonesianphytoconstituentsaspotentialinhibitorsofperoxisomeproliferatoractivatedreceptorgammainpolycysticovarysyndrome